カテゴリー： Transparency Market Research, 世界, 医療/バイオ

世界の外骨格市場2022年-2032年：モビリティ別（携帯、固定/据置）、技術別、四肢別、エンドユーザー別、地域別

◆英語タイトル：Global Exoskeleton Market by Mobility (Mobile, Fixed/Stationary), by Technology (Powered, Non-Powered), by Extremity (Upper Body, Lower Body, Full Body), by End-User (Healthcare, Military, Industry), and by Region - 2022 to 2032

Transparency Market Researchが発行した調査報告書（TMR23JN089）◆商品コード：TMR23JN089
◆発行会社（リサーチ会社）：Transparency Market Research
◆発行日：2022年11月7日
◆ページ数：250
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後24時間以内）
◆調査対象地域：グローバル
◆産業分野：医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧）USD5,795 ⇒換算￥880,840見積依頼/購入/質問フォーム
Multi User（5名様閲覧）USD8,795 ⇒換算￥1,336,840見積依頼/購入/質問フォーム
Corporate License（法人閲覧）USD11,795 ⇒換算￥1,792,840見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Transparency Market Research社の市場調査レポートでは、世界の外骨格市場について調査・分析し、エグゼクティブサマリー、市場概要、リスク・トレンド分析、市場背景、主な成功要因、需要分析・予測、価値分析・予測、モビリティ別（携帯、固定/据置）分析、技術別（電動、非電動）分析、四肢別（上半身、下半身、全身）分析、エンドユーザー別（医療、軍事、工業）分析、地域別（北米、中南米、ヨーロッパ、アジア太平洋、中東・アフリカ）分析、市場構造分析、競合分析、仮定、調査手法などの項目を掲載しています。また、企業情報として、Ekso Bionics、Hocoma、Lockheed Martin Corporation、Rex Bionics Plc、RB3D、ReWalk Robotics Ltd、Cyberdyne, Inc.、ActiveLinkなどがあります。
・エグゼクティブサマリー
・市場概要
・リスク・トレンド分析
・市場背景
・主な成功要因
・需要分析・予測
・価値分析・予測
・世界の外骨格市場規模：モビリティ別
- 携帯型外骨格の市場規模
- 固定/据置型外骨格の市場規模
・世界の外骨格市場規模：技術別
- 電動式外骨格の市場規模
- 非電動式外骨格の市場規模
・世界の外骨格市場規模：四肢別
- 上半身における市場規模
- 下半身における市場規模
- 全身における市場規模
・世界の外骨格市場規模：エンドユーザー別
- 医療における市場規模
- 軍事における市場規模
- 工業における市場規模
・世界の外骨格市場規模：地域別
- 北米の外骨格市場規模
- 中南米の外骨格市場規模
- ヨーロッパの外骨格市場規模
- アジア太平洋の外骨格市場規模
- 中東・アフリカの外骨格市場規模
・市場構造分析
・競合分析
・仮定
・調査手法

Exoskeleton Market – Scope of Report
TMR’s report on the global exoskeleton market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global exoskeleton market for the period 2017–2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global exoskeleton market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the exoskeleton market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global exoskeleton market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global exoskeleton market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global exoskeleton market.

The report delves into the competitive landscape of the global exoskeleton market. Key players operating in the global exoskeleton market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global exoskeleton market profiled in this report.

RESEARCH METHODOLOGY

The research methodology will be a combination of exhaustive primary and secondary research to analyze the market exoskeleton.

Secondary Research

Secondary research includes a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants’ insights, and recognizing business opportunities.

Secondary research sources that we typically refer, but are not limited to:

Company websites, presentations, annual reports, white papers, technical paper, product brochure
Internal and external proprietary databases and relevant patents
National government documents, statistical databases, and market reports
News articles, press releases, and webcasts specific to companies operating in the market

Specific Secondary Sources:

Industry Sources:
WorldWideScience.org
Elsevier, Inc.
National Institutes of Health (NIH)
PubMed
NCBI
Department of Health Care Service
Trade Data Sources
Trade Map
UN Comtrade
Trade Atlas
Company Information
OneSource Business Browser
Hoover’s
Factiva
Bloomberg
Mergers & Acquisitions
Thomson Mergers & Acquisitions
MergerStat
Profound

Primary Research

During the course of research, we conduct in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents bulk of research efforts, supplemented by extensive secondary research.

We conduct primary interviews on the ongoing basis with industry participants and commentators to validate data and analysis. A typical research interview fulfills the following functions:

Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
Helps in validating and strengthening secondary research findings
Further develops the analysis team’s expertise and market understanding
Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies

Participants who typically take part in such a process include, but are not limited to:

Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
Purchasing/Sourcing managers, technical personnel, distributors
Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets
Key opinion leaders specializing in different areas corresponding to different industry verticals

List of primary participants, but not limited to:

Advanced Oncotherapy PLC
Danfysik A/S
Hitachi, Ltd.
IBA Worldwide
Mevion Medical Systems, Inc.

Data Triangulation: Information culled from “Secondary & Primary Sources” is cross-checked with “TMR Knowledge Repository”, which is updated every quarter.

Market Estimation: Market size estimations involved in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we employed modeling techniques in order to produce comprehensive datasets. A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:

Demographic Data: Healthcare expenditure, inflation rates, and others
Industry Indicators: R&D investment, technology stage, and infrastructure, sector growth, and facilities

Market Forecasting: Market forecasts for various segments are derived taking into account drivers, restraints/challenges, and opportunities prevailing in the market and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise surgery data are some of the other pivotal factors, which are considered to derive market forecasts.

❖ レポートの目次 ❖

1. Executive Summary
1.1. Global Market Outlook
1.2. Summary of Statistics
1.3. Key Market Characteristics & Attributes
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage
2.2. Market Definition
3. Market Risks and Trends Assessment
3.1. Risk Assessment
3.1.1. COVID-19 Crisis and Impact on Exoskelton
3.1.2. COVID-19 Impact Benchmark with Previous Crisis
3.1.3. Impact on Market Value (US$Bn)
3.1.4. Assessment by Key Countries
3.1.5. Assessment by Key Market Segments
3.1.6. Action Points and Recommendation for Suppliers
3.2. Key Trends Impacting the Market
3.3. Formulation and Product Development Trends
4. Market Background
4.1. Exoskeleton Market, by Key Countries
4.2. Exoskeleton Market Opportunity Assessment (US$Bn)
4.2.1. Total Available Market
4.2.2. Serviceable Addressable Market
4.2.3. Serviceable Obtainable Market
4.3. Market Scenario Forecast
4.3.1. Demand in optimistic Scenario
4.3.2. Demand in Likely Scenario
4.3.3. Demand in Conservative Scenario
4.4. Investment Feasibility Analysis
4.4.1. Investment in Established Markets
4.4.1.1. In Short Term
4.4.1.2. In Long Term
4.4.2. Investment in Emerging Markets
4.4.2.1. In Short Term
4.4.2.2. In Long Term
4.5. Forecast Factors – Relevance & Impact
4.5.1. Top Companies Historical Growth
4.5.2. Growth in Automation, By Country
4.5.3. Security Testing Adoption Rate, By Country
4.6. Market Dynamics
4.6.1. Market Driving Factors and Impact Assessment
4.6.2. Prominent Market Challenges and Impact Assessment
4.6.3. Exoskeleton Market Opportunities
4.6.4. Prominent Trends in the Global Market & Their Impact Assessment
5. Key Success Factors
5.1. Manufacturers’ Focus on Low Penetration High Growth Markets
5.2. Banking on with Segments High Incremental Opportunity
5.3. Peer Benchmarking
6. Global Exoskeleton Market Demand Analysis 2017-2021 and Forecast, 2022-2032
6.1. Historical Market Analysis, 2017-2021
6.2. Current and Future Market Projections, 2022-2032
6.3. Y-o-Y Growth Trend Analysis
7. Global Exoskeleton Market Value Analysis 2017-2021 and Forecast, 2022-2032
7.1. Historical Market Value (US$Bn) Analysis, 2017-2021
7.2. Current and Future Market Value (US$Bn) Projections, 2022-2032
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Global Exoskeleton Market Analysis 2017-2021 and Forecast 2022-2032, By Mobility
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$Bn) Analysis By Mobility, 2017-2021
8.3. Current and Future Market Size (US$Bn) Analysis and Forecast By Mobility, 2022-2032
8.3.1. Mobile
8.3.2. Fixed/Stationary
8.4. Market Attractiveness Analysis By Mobility
9. Global Exoskeleton Market Analysis 2017-2021 and Forecast 2022-2032, By Technology
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$Bn) Analysis By Technology , 2017-2021
9.3. Current and Future Market Size (US$Bn) Analysis and Forecast By Technology , 2022-2032
9.3.1. Powered
9.3.2. Non-Powered
9.4. Market Attractiveness Analysis By Technology
10. Global Exoskeleton Market Analysis 2017-2021 and Forecast 2022-2032, By Extremity
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$Bn) Analysis By Extremity, 2017-2021
10.3. Current and Future Market Size (US$Bn) Analysis and Forecast By Extremity, 2022-2032
10.3.1. Upper Body
10.3.2. Lower Body
10.3.3. Full Body
10.4. Market Attractiveness Analysis By Extremity
11. Global Exoskeleton Market Analysis 2017-2021 and Forecast 2022-2032, By End-User
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$Bn) Analysis By End-User, 2017-2021
11.3. Current and Future Market Size (US$Bn) Analysis and Forecast By End-User, 2022-2032
11.3.1. Healthcare
11.3.2. Military
11.3.3. Industry
11.4. Market Attractiveness Analysis By End-User
12. Global Exoskeleton Market Analysis 2017-2021 and Forecast 2022-2032, By Region
12.1. Introduction
12.2. Historical Market Size (US$Bn) Analysis By Region, 2017-2021
12.3. Current Market Size (US$Bn) & Analysis and Forecast By Region, 2022-2032
12.3.1. North America
12.3.2. Latin America
12.3.3. Europe
12.3.4. Asia Pacific
12.3.5. Middle East and Africa (MEA)
12.4. Market Attractiveness Analysis By Region
13. North America Exoskeleton Market Analysis 2017-2021 and Forecast 2022-2032
13.1. Introduction
13.2. Pricing Analysis
13.3. Historical Market Value (US$Bn) Trend Analysis By Market Taxonomy, 2017-2021
13.4. Market Value (US$Bn) & Forecast By Market Taxonomy, 2022-2032
13.4.1. By Country
13.4.1.1. U.S.
13.4.1.2. Canada
13.4.1.3. Rest of North America
13.4.2. By Mobility
13.4.3. By Technology
13.4.4. By End-User
13.4.5. By Extremity
13.5. Market Attractiveness Analysis
13.5.1. By Country
13.5.2. By Mobility
13.5.3. By Technology
13.5.4. By End-User
13.5.5. By Extremity
14. Latin America Exoskeleton Market Analysis 2017-2021 and Forecast 2022-2032
14.1. Introduction
14.2. Pricing Analysis
14.3. Historical Market Value (US$Bn) Trend Analysis By Market Taxonomy, 2017-2021
14.4. Market Value (US$Bn) & Forecast By Market Taxonomy, 2022-2032
14.4.1. By Country
14.4.1.1. Brazil
14.4.1.2. Mexico
14.4.1.3. Rest of Latin America
14.4.2. By Mobility
14.4.3. By Technology
14.4.4. By End-User
14.4.5. By Extremity
14.5. Market Attractiveness Analysis
14.5.1. By Country
14.5.2. By Mobility
14.5.3. By Technology
14.5.4. By End-User
14.5.5. By Extremity
15. Europe Exoskeleton Market Analysis 2017-2021 and Forecast 2022-2032
15.1. Introduction
15.2. Pricing Analysis
15.3. Historical Market Value (US$Bn) Trend Analysis By Market Taxonomy, 2017-2021
15.4. Market Value (US$Bn) & Forecast By Market Taxonomy, 2022-2032
15.4.1. By Country
15.4.1.1. Germany
15.4.1.2. France
15.4.1.3. U.K.
15.4.1.4. Italy
15.4.1.5. Spain
15.4.1.6. Russia
15.4.1.7. Rest of Europe
15.4.2. By Mobility
15.4.3. By Technology
15.4.4. By End-User
15.4.5. By Extremity
15.5. Market Attractiveness Analysis
15.5.1. By Country
15.5.2. By Mobility
15.5.3. By Technology
15.5.4. By End-User
15.5.5. By Extremity
16. Asia Pacific Exoskeleton Market Analysis 2017-2021 and Forecast 2022-2032
16.1. Introduction
16.2. Pricing Analysis
16.3. Historical Market Value (US$Bn) Trend Analysis By Market Taxonomy, 2017-2021
16.4. Market Value (US$Bn) & Forecast By Market Taxonomy, 2022-2032
16.4.1. By Country
16.4.1.1. China
16.4.1.2. Japan
16.4.1.3. South Korea
16.4.1.4. India
16.4.1.5. Australia
16.4.1.6. South Korea
16.4.1.7. Rest of Asia Pacific
16.4.2. By Mobility
16.4.3. By Technology
16.4.4. By End-User
16.4.5. By Extremity
16.5. Market Attractiveness Analysis
16.5.1. By Country
16.5.2. By Mobility
16.5.3. By Technology
16.5.4. By End-User
16.5.5. By Extremity
17. Middle East and Africa Exoskeleton Market Analysis 2017-2021 and Forecast 2022-2032
17.1. Introduction
17.2. Pricing Analysis
17.3. Historical Market Value (US$Bn) Trend Analysis By Market Taxonomy, 2017-2021
17.4. Market Value (US$Bn) & Forecast By Market Taxonomy, 2022-2032
17.4.1. By Country
17.4.1.1. UAE
17.4.1.2. South Africa
17.4.1.3. Saudi Arabia
17.4.1.4. Israel
17.4.1.5. Rest of Middle East and Africa
17.4.2. By Mobility
17.4.3. By Technology
17.4.4. By End-User
17.4.5. By Extremity
17.5. Market Attractiveness Analysis
17.5.1. By Country
17.5.2. By Mobility
17.5.3. By Technology
17.5.4. By End-User
17.5.5. By Extremity
18. Key Countries Exoskeleton Market Analysis 2017-2021 and Forecast 2022-2032
18.1. Introduction
18.1.1. Market Value Proportion Analysis, By Key Countries
18.1.2. Global Vs. Country Growth Comparison
18.2. US Exoskeleton Market Analysis
18.2.1. Value Proportion Analysis by Market Taxonomy
18.2.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
18.2.2.1. By Mobility
18.2.2.2. By Technology
18.2.2.3. By End-User
18.2.2.4. By Extremity
18.3. Canada Exoskeleton Market Analysis
18.3.1. Value Proportion Analysis by Market Taxonomy
18.3.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
18.3.2.1. By Mobility
18.3.2.2. By Technology
18.3.2.3. By End-User
18.3.2.4. By Extremity
18.4. Mexico Exoskeleton Market Analysis
18.4.1. Value Proportion Analysis by Market Taxonomy
18.4.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
18.4.2.1. By Mobility
18.4.2.2. By Technology
18.4.2.3. By End-User
18.4.2.4. By Extremity
18.5. Brazil Exoskeleton Market Analysis
18.5.1. Value Proportion Analysis by Market Taxonomy
18.5.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
18.5.2.1. By Mobility
18.5.2.2. By Technology
18.5.2.3. By End-User
18.5.2.4. By Extremity
18.6. Germany Exoskeleton Market Analysis
18.6.1. Value Proportion Analysis by Market Taxonomy
18.6.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
18.6.2.1. By Mobility
18.6.2.2. By Technology
18.6.2.3. By End-User
18.6.2.4. By Extremity
18.7. France Exoskeleton Market Analysis
18.7.1. Value Proportion Analysis by Market Taxonomy
18.7.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
18.7.2.1. By Mobility
18.7.2.2. By Technology
18.7.2.3. By End-User
18.7.2.4. By Extremity
18.8. Italy Exoskeleton Market Analysis
18.8.1. Value Proportion Analysis by Market Taxonomy
18.8.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
18.8.2.1. By Mobility
18.8.2.2. By Technology
18.8.2.3. By End-User
18.8.2.4. By Extremity
18.9. Spain Exoskeleton Market Analysis
18.9.1. Value Proportion Analysis by Market Taxonomy
18.9.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
18.9.2.1. By Mobility
18.9.2.2. By Technology
18.9.2.3. By End-User
18.9.2.4. By Extremity
18.10. UK Exoskeleton Market Analysis
18.10.1. Value Proportion Analysis by Market Taxonomy
18.10.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
18.10.2.1. By Mobility
18.10.2.2. By Technology
18.10.2.3. By End-User
18.10.2.4. By Extremity
18.11. Russia Exoskeleton Market Analysis
18.11.1. Value Proportion Analysis by Market Taxonomy
18.11.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
18.11.2.1. By Mobility
18.11.2.2. By Technology
18.11.2.3. By End-User
18.11.2.4. By Extremity
18.12. China Exoskeleton Market Analysis
18.12.1. Value Proportion Analysis by Market Taxonomy
18.12.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
18.12.2.1. By Mobility
18.12.2.2. By Technology
18.12.2.3. By End-User
18.12.2.4. By Extremity
18.13. Japan Exoskeleton Market Analysis
18.13.1. Value Proportion Analysis by Market Taxonomy
18.13.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
18.13.2.1. By Mobility
18.13.2.2. By Technology
18.13.2.3. By End-User
18.13.2.4. By Extremity
18.14. South Korea Exoskeleton Market Analysis
18.14.1. Value Proportion Analysis by Market Taxonomy
18.14.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
18.14.2.1. By Mobility
18.14.2.2. By Technology
18.14.2.3. By End-User
18.14.2.4. By Extremity
18.15. UAE Exoskeleton Market Analysis
18.15.1. Value Proportion Analysis by Market Taxonomy
18.15.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
18.15.2.1. By Mobility
18.15.2.2. By Technology
18.15.2.3. By End-User
18.15.2.4. By Extremity
18.16. South Africa Exoskeleton Market Analysis
18.16.1. Value Proportion Analysis by Market Taxonomy
18.16.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
18.16.2.1. By Mobility
18.16.2.2. By Technology
18.16.2.3. By End-User
18.16.2.4. By Extremity
18.17. Saudi Arabia Exoskeleton Market Analysis
18.17.1. Value Proportion Analysis by Market Taxonomy
18.17.2. Value Analysis and Forecast by Market Taxonomy, 2017-2032
18.17.2.1. By Mobility
18.17.2.2. By Technology
18.17.2.3. By End-User
18.17.2.4. By Extremity
18.17.3. Competition Landscape and Player Concentration in the Country
19. Market Structure Analysis
19.1. Market Analysis by Tier of Companies
19.2. Market Concentration
19.3. Market Share Analysis of Top Players
19.4. Market Presence Analysis
19.4.1. By Regional footprint of Players
19.4.2. Product footprint by Players
20. Competition Analysis
20.1. Competition Dashboard
20.2. Competition Benchmarking
20.3. Competition Deep Dive
20.3.1. IBM
20.3.1.1. Overview
20.3.1.2. Product Portfolio
20.3.1.3. Sales Footprint
20.3.1.4. Strategy Overview
20.3.2. Ekso Bionics
20.3.2.1. Overview
20.3.2.2. Product Portfolio
20.3.2.3. Sales Footprint
20.3.2.4. Strategy Overview
20.3.3. Hocoma
20.3.3.1. Overview
20.3.3.2. Product Portfolio
20.3.3.3. Sales Footprint
20.3.3.4. Strategy Overview
20.3.4. Lockheed Martin Corporation
20.3.4.1. Overview
20.3.4.2. Product Portfolio
20.3.4.3. Sales Footprint
20.3.4.4. Strategy Overview
20.3.5. Rex Bionics Plc
20.3.5.1. Overview
20.3.5.2. Product Portfolio
20.3.5.3. Sales Footprint
20.3.5.4. Strategy Overview
20.3.6. RB3D
20.3.6.1. Overview
20.3.6.2. Product Portfolio
20.3.6.3. Sales Footprint
20.3.6.4. Strategy Overview
21. Assumptions and Acronyms Used
22. Research Methodology



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 世界の外骨格市場2022年-2032年：モビリティ別（携帯、固定/据置）、技術別、四肢別、エンドユーザー別、地域別(Global Exoskeleton Market by Mobility (Mobile, Fixed/Stationary), by Technology (Powered, Non-Powered), by Extremity (Upper Body, Lower Body, Full Body), by End-User (Healthcare, Military, Industry), and by Region - 2022 to 2032)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 世界のクリーンルーム技術市場2022年-2032年：製品種類別（機器、消耗品）、エンドユーザー別、地域別
  • 世界の義歯市場2022年-2032年：種類別（部分義歯、総義歯）、用途別、エンドユーザー別
  • 世界のコールドプラズマ市場2022年-2032年：レジーム別（大気圧コールドプラズマ、低圧コールドプラズマ）、エンドユーザー別、地域別
  • 世界の近赤外イメージング市場2022年-2032年：用途別（前臨床イメージング、癌外科手術、消化器外科手術、心臓血管外科、プラスチック/再建手術、その他）、エンドユーザー別、地域別

    • ◆H&Iグローバルリサーチのお客様（例）◆